Picture of Prophase Labs logo

PRPH Prophase Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Prophase Labs Inc expected to post a loss of 9 cents a share - Earnings Preview

* Prophase Labs Inc  PRPH.OQ   PRPH.O  is expected to show a
fall
in quarterly revenue when it reports  results on May 11. 
    * The New York City-based  company is expected to report  a
65.7% decrease in revenue to $16.3 million from $47.53 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
a loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Prophase
Labs Inc
is $16​, above​ its last closing price of $8.37. ​​​

This summary was machine generated May 9 at 13:52 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Prophase Labs

See all news